Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|August 19, 2005
Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cellsMurielle Mimeault, Erik Moore, Nicolas Moniaux, et al.Growth Factors (Chur, Switzerland)|March 28, 2008
Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascadesMurielle Mimeault, Parmender P Mehta, Ralph Hauke, et al.Bioorganic & Medicinal Chemistry|November 4, 2015
Synthesis and biological evaluation of di-aryl urea derivatives as c-Kit inhibitorsSéverine Ravez, Stéphane Arsenlis, Amélie Barczyk, et al.Chemmedchem|January 9, 2007
Derivatives of Iressa, a specific epidermal growth factor receptor inhibitor, are powerful apoptosis inducers in PC3 prostatic cancer cellsAurélie Telliez, Matthieu Desroses, Nicole Pommery, et al.Molecular Cancer Therapeutics|March 17, 2007
Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cellsMurielle Mimeault, Sonny L Johansson, Ganesh Vankatraman, et al.RSC Medicinal Chemistry|March 10, 2025
Design, synthesis and evaluation of pyrimidinobenzylamide and pyrimidinothiophenamide derivatives as inhibitors of DOT1L and related epigenetic targets DNMT3a, PRMT4 and other HMTsOscar Omar Castillo-Aguilera, Patrick Depreux, Ludovic Halby, et al.International Journal of Cancer|October 3, 2006
Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposideMurielle Mimeault, Ganesh Venkatraman, Sonny L Johansson, et al.Analytical Biochemistry|August 4, 2016
Amine coupling versus biotin capture for the assessment of sulfonamide as ligands of hCA isoformsTiphaine Rogez-Florent, Laurence Goossens, Anne-Sophie Drucbert, et al.Journal of Medicinal Chemistry|January 6, 2006
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modelingEric Stern, Giulio G Muccioli, Régis Millet, et al.Journal of Medicinal Chemistry|October 6, 2007
Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionalityEric Stern, Giulio G Muccioli, Barbara Bosier, et al.Pageof 3